Effective treatment with rituximab for the maintenance of remission in frequently relapsing minimal change disease

AIM: Treatment of frequently relapsing or steroid‐dependent minimal change disease (MCD) in children and adults remains challenging. Glucocorticoids and/or other immunosuppressive agents are the mainstay of treatment, but patients often experience toxicity from prolonged exposure and may either beco...

Descripción completa

Detalles Bibliográficos
Autores principales: Papakrivopoulou, Eugenia, Shendi, Ali M., Salama, Alan D., Khosravi, Maryam, Connolly, John O., Trompeter, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026064/
https://www.ncbi.nlm.nih.gov/pubmed/26860320
http://dx.doi.org/10.1111/nep.12744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026064/
https://www.ncbi.nlm.nih.gov/pubmed/26860320
http://dx.doi.org/10.1111/nep.12744

Ejemplares similares